drug
zoliflodacin
Marketedupdated 3mo agoby Entasis Therapeutics Holdings Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 13, 2029
~3.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Jan 21, 2034compositionUS 8889671
- Jan 21, 2034compositionUS 9187495
- Jan 21, 2034method-of-use (U-4369)US 9540394
- Jan 21, 2034method-of-use (U-4369)US 9839641
- Jun 20, 2030compositionUS 86586413.8y
- Oct 13, 2029method-of-use (U-4369)US 90405283.1y
FDA exclusivities (2)
- Dec 12, 2035GAINGAIN Antibiotic (5y)
- Dec 12, 2030NCENew Chemical Entity (5y)4.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that